Glenda Halliday | |
---|---|
Occupation | Neuroscientist |
Awards | NSW Scientist of the Year (2022) |
Academic background | |
Alma mater | University of New South Wales |
Thesis | The organization of the ventromedial mesencephalic tegmentum (1986) |
Academic work | |
Institutions | University of New South Wales University of Sydney |
Glenda Margaret Halliday AC FAA FAHMS is an Australian neuroscientist. As of 2021,she is a professor at the University of Sydney and research fellow in the National Health and Medical Research Council (NHMRC). She was named 2022 NSW Scientist of the Year.
Halilday graduated with a BSc from the University of New South Wales (UNSW) in 1981. [1] She went on to graduate with a PhD from the Faculty of Medicine at the UNSW in 1986,with a thesis titled "The organization of the ventromedial mesencephalic tegmentum". [2] While undertaking her PhD she founded a donor program to enable study of Parkinson's disease in the brain.
Halliday is a research fellow of the NHMRC,first appointed to that role in 1990. [3] Working at UNSW,she was appointed professor of medicine in 2003 and subsequently professor of neuroscience in 2008. As of 2021 she is a professor and NHMRC leadership fellow based at the University of Sydney. [4]
Halliday's research focuses on neurodegeneration,including Parkinson's disease and frontotemporal dementia. [5] Her work has led to improved treatment of Parkinson's sufferers.
Halliday was elected a Fellow of the Australian Academy of Health and Medical Sciences in 2015 [6] and Fellow of the Australian Academy of Science in May 2021. [7] She was awarded the 2020 NHMRC Elizabeth Blackburn Investigator Grant Award for Leadership in Clinical Medicine and Science [8] and in 2021 won the international Robert A. Pritzker Prize for Leadership in Parkinson's Research. [9] She was named NSW Scientist of the Year at the 2022 NSW Premier's Prizes for Science and Engineering recognising her research on neurodegenerative diseases. [10]
Halliday was appointed as a Companion of the Order of Australia in the 2023 King's Birthday Honours for "eminent service to medical research in the field of neurodegenerative disorders,including the development of revised diagnostic criteria for Parkinson's disease,and as a mentor". [11]
Neuroscience Research Australia is an independent,not for profit medical research institute based in Sydney,Australia.
Helen Christensen (AO) is the Scientia Professor of Mental Health at the University of New South Wales in Sydney. She has been the Board Director of the Black Dog Institute since 2022. She is also a former executive director and Chief Scientist at the Institute,having led the organisation from 2011 to 2021.
Katharina Gaus was a German-Australian immunologist and molecular microscopist. She was an NHMRC Senior Research Fellow and founding head of the Cellular Membrane Biology Lab,part of the Centre for Vascular Research at the University of New South Wales. Gaus used new super-resolution fluorescence microscopes to examine the plasma membrane within intact living cells,and study cell signalling at the level of single molecules to better understand how cells "make decisions". A key discovery of Gaus and her team was how T-cells decide to switch on the body's immune system to attack diseases. Her work is of importance to the development of drugs that can work with T-cells in support of the immune system.
Aleksandra Filipovska is a Professor,Deputy Director of the ARC Centre of Excellence in Synthetic Biology and NHMRC Investigator at the University of Western Australia,heading a research group at the Telethon Kids Institute. Specializing in biochemistry and molecular biology,she has made contributions to the understanding of human mitochondrial genetics in health and disease.
Michelle Haber is an Australian cancer researcher.
George Paxinos AO DSc FASSA FAA FRSN FAHMS is a Greek Australian neuroscientist,born in Ithaca,Greece. He completed his BA in psychology at the University of California at Berkeley and his PhD at McGill University in Montreal,Canada. After a postdoctoral year at Yale University,he moved to the School of Psychology of the University of New South Wales in Sydney,Australia. He is currently an NHMRC Senior Principal Research Fellow at Neuroscience Research Australia and Scientia Professor of Medical Sciences at the University of New South Wales.
David Albert Cooper was an Australian HIV/AIDS researcher,immunologist,professor at the University of New South Wales,and the director of the Kirby Institute. He and Professor Ron Penny diagnosed the first case of HIV in Australia.
Bryce Vissel is an Australian neuroscientist who is a professor of neuroscience at the University of New South Wales. He is the Director of the Centre for Neuroscience and Regenerative Medicine (CNRM) at St Vincent's Hospital Sydney. He is a specialist in neurodegenerative diseases,such as Alzheimer's,Parkinson's,and the neural basis of learning,memory and movement.
Maree Rose Teesson,FAAHMS,FASSA,is an Australian expert on mental health. She is the Director of The Matilda Centre for Research in Mental Health and Substance Use and NHMRC Principal Research Fellow at the University of Sydney. She is also professorial fellow at the Black Dog Institute,UNSW.
Susan Margaret Pond is an Australian scientist and technologist,active in business and academia,and recognised for her contributions to medicine,biotechnology,renewable energy and sustainability. She is the current president of the Royal Society of New South Wales.
Maria Kavallaris is an Australian scientist,based at the University of New South Wales' Children's Cancer Institute,where she is best known for her contributions to the field of cancer research. On 25 January 2019,Kavallaris was appointed a member of the Order of Australia.
Kaarin Anstey is an Australian Laureate Fellow and one of Australia's top dementia scientists. She is Co-Deputy Director of the ARC Centre of Excellence in Population Ageing Research (CEPAR) at the University of New South Wales,Australia,where she is Scientia Professor of Psychology. Kaarin Anstey is an Honorary Professor at the Australian National University and a Fellow of the Academy of the Social Sciences in Australia. She is a Director of the NHMRC Dementia Centre for Research Collaboration,Senior Principal Research Scientist at NeuRA and leads the NHMRC Centre of Research Excellence in Cognitive Health and the UNSW Ageing Futures Institute.
Professor Susan J. Clark is an Australian biomedical researcher in epigenetics of development and cancer. She was elected a Fellow of the Australian Academy of Science in 2015,and is a National Health and Medical Research Council (NHMRC) Senior Principal Research Fellow and Research Director and Head of Genomics and Epigenetics Division at the Garvan Institute of Medical Research. Clark developed the first method for bisulphite sequencing for DNA methylation analysis and used it to establish that the methylation machinery of mammalian cells is capable of both maintenance and de novo methylation at CpNpG sites and showed is inheritable. Clark's research has advanced understanding of the role of DNA methylation,non-coding RNA and microRNA in embryogenesis,reprogramming,stem cell development and cancer and has led to the identification of epigenomic biomarkers in cancer. Clark is a founding member of the International Human Epigenome Consortium (IHEC) and President of the Australian Epigenetics Alliance (AEpiA).
Bettina Meiser is a professor at the University of New South Wales,with expertise in the psychosocial aspects of genetics;cancer,hereditary cancer,and the impact of genetic counselling and testing.
Anushka Patel is Chief Executive Officer at The George Institute for Global health,a Professor of Medicine at the University of New South Wales,and Cardiologist at the Royal Prince Alfred Hospital.
Lisa Maher is Professor and head of Viral Hepatitis Epidemiology,at the Kirby Institute for Infection and Immunity,at the University of New South Wales and was made Member of the Order of Australia in 2015. She was awarded an Elizabeth Blackburn Fellowship,in Public Health from the NHMRC,in 2014. She is a fellow of the Australian Academy of Health and Medical Sciences.
Louise Maple-Brown is an Australian endocrinologist. She is a clinical researcher at the Royal Darwin Hospital,serving as the hospital's Head of Endocrinology and as NHMRC Practitioner Fellow with the Menzies School of Health Research at Charles Darwin University. She leads a clinical research program within the Wellbeing and Preventable Chronic Diseases division of Menzies with a focus on diabetes in Indigenous Australians and provides clinical diabetes services to urban and remote Northern Territory communities.
Emily Banks is an Australian epidemiologist and public health physician,working mainly on chronic disease. She is a Professor of Epidemiology and Public Health and Head of the Centre for Public Health Data and Policy at the Australian National University,and a visiting professor at the University of Oxford.
Raina MacIntyre is an Australian epidemiologist and academic. She is the Professor of Global Biosecurity within the Kirby Institute at University of New South Wales and a National Health and Medical Research Council Principal Research Fellow,who leads a research program on the prevention and control of infectious diseases. She is an expert media advisor and commentator on Australia's response to COVID-19.
Carolyn Mary Sue is an Australian physician-scientist,professor and research director. She has been the Executive Director of the Kolling Institute of Medical Research since 2019 and is also Director of Neurogenetics at Royal North Shore Hospital,Director of the Centre of Excellence for Parkinson's Disease and Movement Disorders,and Director of the National Centre for Adult Stem Cell Research. Sue specialises in complex neurogenetic conditions and runs tertiary referral clinics for patients with diseases such as Parkinson's,mitochondrial diseases,and other inherited movement disorders. Her research has identified several previously-unknown mutations that cause neurogenetic disease.